Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Abstract

Summary Background The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) averted by vaccination against ten pathogens in 98 LMICs between 2000 and 2030. Methods 16 independent research groups provided model-based disease burden estimates under a range of vaccination coverage scenarios for ten pathogens: hepatitis B virus, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, Streptococcus pneumoniae , rotavirus, rubella, and yellow fever. Using standardised demographic data and vaccine coverage, the impact of vaccination programmes was determined by comparing model estimates from a no-vaccination counterfactual scenario with those from a reported and projected vaccination scenario. We present deaths and DALYs averted between 2000 and 2030 by calendar year and by annual birth cohort. Findings We estimate that vaccination of the ten selected pathogens will have averted 69 million (95% credible interval 52–88) deaths between 2000 and 2030, of which 37 million (30–48) were averted between 2000 and 2019. From 2000 to 2019, this represents a 45% (36–58) reduction in deaths compared with the counterfactual scenario of no vaccination. Most of this impact is concentrated in a reduction in mortality among children younger than 5 years (57% reduction [52–66]), most notably from measles. Over the lifetime of birth cohorts born between 2000 and 2030, we predict that 120 million (93–150) deaths will be averted by vaccination, of which 58 million (39–76) are due to measles vaccination and 38 million (25–52) are due to hepatitis B vaccination. We estimate that increases in vaccine coverage and introductions of additional vaccines will result in a 72% (59–81) reduction in lifetime mortality in the 2019 birth cohort. Interpretation Increases in vaccine coverage and the introduction of new vaccines into LMICs have had a major impact in reducing mortality. These public health gains are predicted to increase in coming decades if progress in increasing coverage is sustained. Funding Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.

Hospital Costs of Immunopreventable Diseases in the Economically Active Population in Brazil

“…The main objective of this manuscript is not to determine the causal relationship for hospital costs for preventable diseases. The merit of this study is that it signals a reality that often goes unnoticed to the managers of the health system and the population: that diseases that are effectively preventable by vaccines still affect the Brazilian population, in a relevant amount, adding financial costs also relevant to the country's public health system, regardless of gender and age (because here in this analysis we observe cases of immunopreventable diseases not only in children, but also in adults and the elderly, a reality observed internationally) (16)(17)(18)(19)(20). These costs are not showing downward trends, but rather, they are proving stable over the time studied, even though vaccines are available free of charge to the entire population by the National Immunization Program for many years.…”

Vaccination strategies for a seasonal epidemic: a simple SIR model

“…Just before the emergence of the COVID-19 epidemic, Widyaningsih et al [11] studied the effect of vaccination on tuberculosis transmission in Indonesia. A vast collaboration within the Vaccine Impact Modelling Consortium [12] addressed the question of the impact on health of vaccination against a collection of pathogens. They concluded, on the basis of the results of their model, that millions of deaths may be averted, compared to the (admittedly counterfactual) scenario of non-vaccination.…”

Timeliness of routine childhood vaccination in low- and middle-income countries, 1978–2021: Protocol for a scoping review to map methodologic gaps and determinants

“…Globally, about 2–3 million deaths from diseases such as diphtheria, tetanus, pertussis and measles are prevented yearly with lifesaving childhood vaccines [ 2 ]. In low-and middle-income countries (LMICs), current estimates suggest that between 2000 and 2019, 36 million deaths have been averted among children under 5 by vaccination programmes [ 3 ]. Although EPI has drastically reduced the incidence of, and deaths from VPDs, its success across and within countries vary, especially in LMICs.…”